Literature DB >> 8813090

Postoperative thrombotic thrombocytopenic purpura following cardiovascular surgeries.

J C Chang1, A Shipstone, M A Llenado-Lee.   

Abstract

Among 47 patients with thrombotic thrombocytopenic purpura (TTP), 8 patients were diagnosed to have postoperative-TTP. Two patients underwent vascular surgery, 5 patients coronary artery bypass grafts, and 1 patient resection of myocardial sarcoma. Prior to surgery, all patients except one had normal hemograms and platelet counts, and blood smears showed no schistocytes. Five to 19 days after surgery, all 8 patients developed postoperative TTP, which clinical feature was characterized by unexplained progressive encephalopathy, thrombocytopenia, and microangiopathic hemolytic anemia. In addition, in 3 patients, progressive gangrene of the toes also developed. Four patients achieved complete remission following exchange plasmapheresis and 1 patient spontaneous remission. Due to complicated surgical settings after surgery, recognition of TTP was often delayed and it contributed to death in 3 patients despite treatment with exchange plasmapheresis. In view of occurrence of postoperative TTP following cardiac and vascular surgeries, pathogenic mechanism for postoperative TTP may be explained on the basis of injury of diseased endothelial surface and release of a humoral factor(s) that results in platelet aggregation in the capillaries and arterioles. Our experience with these cases indicates that TTP may occur as a serious complication of cardiac and vascular surgeries, and early recognition of the diagnosis and institution of exchange plasmapheresis are of paramount importance for favorable outcome.

Entities:  

Mesh:

Year:  1996        PMID: 8813090     DOI: 10.1002/(SICI)1096-8652(199609)53:1<11::AID-AJH3>3.0.CO;2-8

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  9 in total

1.  [Thrombotic microangiopathy after extracorporeal circulation: important differential diagnosis].

Authors:  T Schmidt; D A Tsakiris; M Grapow; M Siegemund
Journal:  Anaesthesist       Date:  2010-12-25       Impact factor: 1.041

Review 2.  Recurrent thrombotic thrombocytopenic purpura (TTP) as a complication of acute relapsing pancreatitis.

Authors:  Jayant A Talwalkar; Frederick W Ruymann; Paul Marcoux; Francis A Farraye
Journal:  Dig Dis Sci       Date:  2002-05       Impact factor: 3.199

Review 3.  Postoperative thrombotic thrombocytopenic purpura.

Authors:  Ahmet Emre Eskazan; Deram Buyuktas; Teoman Soysal
Journal:  Surg Today       Date:  2013-12-29       Impact factor: 2.549

4.  Thrombotic Thrombocytopenic Purpura associated with Clopidogrel: a case report and review of the literature.

Authors:  Taleb Azarm; Ayatollah Sohrabi; Hamid Mohajer; Arezou Azarm
Journal:  J Res Med Sci       Date:  2011-03       Impact factor: 1.852

5.  Thrombotic thrombocytopenic purpura after percutaneous coronary intervention.

Authors:  Jung-Min Lee; Seung-Ho Hur; Chang-Wook Nam; Seung-Wook Han; Kee-Sik Kim; Yoon-Nyun Kim; Kwon-Bae Kim
Journal:  Korean J Intern Med       Date:  2006-06       Impact factor: 2.884

Review 6.  New-onset acute thrombocytopenia in hospitalized patients: pathophysiology and diagnostic approach.

Authors:  Naveed Ali; Herbert E Auerbach
Journal:  J Community Hosp Intern Med Perspect       Date:  2017-07-13

Review 7.  TTP-like syndrome: novel concept and molecular pathogenesis of endotheliopathy-associated vascular microthrombotic disease.

Authors:  Jae C Chang
Journal:  Thromb J       Date:  2018-08-11

8.  Acute Respiratory Distress Syndrome as an Organ Phenotype of Vascular Microthrombotic Disease: Based on Hemostatic Theory and Endothelial Molecular Pathogenesis.

Authors:  Jae C Chang
Journal:  Clin Appl Thromb Hemost       Date:  2019 Jan-Dec       Impact factor: 2.389

9.  Prospective Evaluation of the Pre-, Intra-, and Postoperative Kinetics of ADAMTS-13, von Willebrand Factor, and Interleukin-6 in Vascular Surgery.

Authors:  Katja Susanne Häußler; Michael Keese; Christian Friedrich Weber; Christof Geisen; Wolfgang Miesbach
Journal:  Clin Appl Thromb Hemost       Date:  2020 Jan-Dec       Impact factor: 2.389

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.